Cefditoren
Indications
Cefditoren is indicated for the treatment
of mild to moderate infections in adults and adolescents (12 years of
age or older) which are caused by susceptible strains of the designated
microorganisms in the conditions listed below:
- Acute Bacterial Exacerbation of Chronic Bronchitis
- Community Acquired Pneumonia
- Pharyngitis
- Tonsillitis
- Uncomplicated Skin and Skin-Structure Infections
Pharmacology
Cefditoren inhibits the synthesis of
bacterial cell wall. It has high affinity to penicillin-binding proteins
(PBPs) in various bacteria, showing a bactericidal effect.
Dosage
Community-Acquired Pneumonia: 400 mg twice daily for 14 days.
Acute Exacerbation of Chronic Bronchitis: 400 mg twice daily for 10 days.
Pharyngotonsillitis and Acute Sinusitis: 200 mg twice daily for 10 days.
Uncomplicated Skin and Soft Structure Infections: 200 mg twice daily for 10 days.
Acute Exacerbation of Chronic Bronchitis: 400 mg twice daily for 10 days.
Pharyngotonsillitis and Acute Sinusitis: 200 mg twice daily for 10 days.
Uncomplicated Skin and Soft Structure Infections: 200 mg twice daily for 10 days.
Administration
Cefditoren should be taken after meals.
Interaction
Co-administration of a single dose of an
antacid and H2 receptor antagonists may reduce the oral absorption of
cefditoren pivoxil. As with other beta-lactam antibiotics,
co-administration of probenecid with cefditoren pivoxil resulted in an
increase in the plasma exposure of cefditoren.
Contraindications
Contraindicated in patients hypersensitive
to drug or other cephalosporins. Also contraindicated in patients with
carnitine deficiency or inborn errors of metabolism that may result in
clinically significant carnitine deficiency. Because cefditoren tablets
contain sodium caseinate, a milk protein, don't give to patients
hypersensitive to milk protein (as distinct from those with lactose
intolerance).
Side Effects
The most common side effects of Cefditoren
are diarrhea, nausea, headache, abdominal pain, vaginal moniliasis,
dyspepsia, vomiting, abnormal dreams, allergic reaction, anorexia,
constipation, dizziness, dry mouth and fever.
Pregnancy & Lactation
Pregnancy category B.
There are no adequate and well-controlled studies in pregnant women.
Cefditoren should be used during pregnancy only if clearly needed.
Lactation: Animal studies show that Cefditoren excreted in breast milk. Caution should be exercised when Cefditoren is administered to nursing women.
Lactation: Animal studies show that Cefditoren excreted in breast milk. Caution should be exercised when Cefditoren is administered to nursing women.
Precautions & Warnings
Cefditor should be prescribed with caution
in individuals with a history of gastrointestinal diseases, particularly
colitis. Dosage adjustment is only necessary in severe renal failure
(creatinine clearance< 30 ml/min)
Overdose Effects
Information on Cefditoren overdosage in
humans is not available. However, with other ß-lactam antibiotics,
adverse effects following overdosage have included nausea, vomiting,
epigastric distress, diarrhea, and convulsions. Hemodialysis may aid in
the removal of Cefditoren from the body, particularly if renal function
is compromised.
Therapeutic Class
Third generation Cephalosporins
Storage Conditions
Store in a cool (below 25° C) and dry place protected from light.
Showing 1 to 5 of 5 (1 Pages)